Literature DB >> 29686318

Microcirculation and biomarkers in patients with resistant or mild-to-moderate hypertension: a cross-sectional study.

Camillo L C Junqueira1, Maria Eliane C Magalhães2, Andréa Araújo Brandão2, Esmeralci Ferreira2, Fátima Z G A Cyrino1, Priscila A Maranhão1, Maria das Graças C Souza1, Daniel Alexandre Bottino3, Eliete Bouskela1.   

Abstract

Microcirculation influences peripheral vascular resistance and therefore contributes to arterial blood pressure. The aim of this study was to investigate the correlation between serum markers of inflammation and microcirculatory parameters observed by nailfold videocapillaroscopy (NVC) in patients with resistant (RH, 58 [50-63] years, n = 25) or mild-to-moderate hypertension (MMH, 56 [47-64] years, n = 25) compared to normotensive patients (control group (CG), 33 [27-52] years, n = 25). C-reactive protein (CRP), endothelin, adiponectin, I-CAM and V-CAM levels were obtained by laboratory analysis. Functional capillary density (FCD; the number of capillaries with flowing red blood cells by unit tissue area), capillary diameters, maximum red blood cell velocity (RBCVmax) during the reactive hyperemia response/RBCVbaseline after 1 min of arterial occlusion at the finger base and time to reach RBCVmax were determined by NVC. A sub-analysis was also conducted on hypertensive patients not taking statins, with controlled/uncontrolled blood pressure. The RH group showed lower RBCV and RBCVmax values and longer TRBCVmax compared to MMH and CG patients, with worse values in those with uncontrolled blood pressure. FCD and diameters showed no significant differences among the three groups, with higher CRP values in the RH and MMH groups. An increase in endothelin was observed only in patients not taking statins in both hypertensive groups. Patients with severe hypertension and uncontrolled blood pressure levels presented more pronounced microvascular dysfunction, as well as higher serum values for CRP and endothelin (without statin treatment), suggesting that the use of statins decreases endothelin release.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29686318     DOI: 10.1038/s41440-018-0043-3

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  5 in total

1.  Association of serum 25-hydroxyvitamin D levels with primary hypertension: a study from south India.

Authors:  Pramod Kumar Kuchulakanti; Jaydip Ray Chaudhuri; Urmila Annad; Naveen Reddy Samala; Lakshumaiah Tallapaneni; Banda Balaraju; Vcs Srinivasarao Bandaru
Journal:  Hypertens Res       Date:  2020-01-21       Impact factor: 3.872

2.  Factors associated with the changes from a resistant to a refractory phenotype in hypertensive patients: a Pragmatic Longitudinal Study.

Authors:  Cristina Navarro-Soriano; Miguel-Angel Martínez-García; Gerard Torres; Ferrán Barbé; Candela Caballero-Eraso; Patricia Lloberes; Trinidad Diaz Cambriles; María Somoza; Juan F Masa; Mónica González; Eva Mañas; Mónica de la Peña; Francisco García-Río; Josep María Montserrat; Alfonso Muriel; Grace Oscullo; Laura Feced Olmos; Alberto García-Ortega; David Calhoun; Francisco Campos-Rodriguez
Journal:  Hypertens Res       Date:  2019-06-17       Impact factor: 3.872

3.  Biomarker-based Inflammatory Score in Obese Patients with Resistant Hypertension.

Authors:  Cibele Isaac Saad Rodrigues
Journal:  Arq Bras Cardiol       Date:  2019-04       Impact factor: 2.000

4.  Analysis of Endothelin-1 Concentrations in Individuals with Periodontitis.

Authors:  Gaetano Isola; Alessandro Polizzi; Angela Alibrandi; Francesco Indelicato; Sebastiano Ferlito
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

5.  Evaluation of demodicosis, nailfold capillaroscopy, and oxidative stress in rosacea: a case-control study.

Authors:  Ezgi Aktaş Karabay; Özlem Unay Demirel
Journal:  Postepy Dermatol Alergol       Date:  2021-09-17       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.